Clarion News

Clarion Announces Partnership with Svoboda Capital Partners


Boston, MA  –  Clarion Healthcare (“Clarion”) is pleased to announce a new equity partnership with Svoboda Capital Partners (“SC”), a Chicago-based private equity firm, to support our continued growth and capitalize on new opportunities for our clients and our people.

Svoboda Capital Partners, founded in 1998, has over $400 million of capital under management and has a track record of successful partnerships and investments in high-value professional services firms. Svoboda shares our long-term vision of building the leading life sciences consultancy and values our successful business model, unique culture, and value proposition to our clients.

“Since Clarion’s inception, our mission has been to positively impact our clients by helping them tackle their toughest and most critical challenges with our fit-for-purpose strategic guidance,” said Tom Murtagh, CEO and co-founder of Clarion. “We accomplish this through a unique combination of entrepreneurial spirit, a rigorous scientific and analytic foundation, and a deep commitment to collaboration. SC truly understands and appreciates the importance of our people and culture, which is one of the reasons why we are so excited to partner with the SC team for our next phase of growth.”

“Helping build and grow Clarion alongside so many incredible colleagues and clients has been a privilege,” said Bart Lombardi, managing director and co-founder of Clarion. “Our passion for finding opportunities where others see challenges has enabled us to consistently advance our clients’ organizations while developing meaningful, long-term relationships. Our partnership with SC will help catalyze Clarion’s growth and find additional ways to deliver long-term value to clients.”

“Clarion is a very impressive organization, delivering high value to clients by bridging the intersection between science and medical know-how with business acumen and commercialization expertise. Our partnership with Clarion is consistent with our firm’s continued focus on investing in and helping build great professional service companies – key tenets of which include preserving culture and reputation while providing the capital and support to help enhance growth,” reflected Ryan Kantor, Vice President at SC.

For more information on Svoboda Capital Partners, please visit

Is Clarion the right place to advance your career?

Find out more about joining Clarion’s team of innovation advisors.

A life sciences strategy and organizational consultancy that collaborates with its clients to envision, craft and enable growth through innovation and leadership.